A Workflow for Exploring Ligand Dissociation from a Macromolecule:
  Efficient Random Acceleration Molecular Dynamics Simulation and Interaction
  Fingerprints Analysis of Ligand Trajectories by Kokha, Daria B. et al.
1 
 
A Workflow for Exploring Ligand Dissociation from a Macromolecule: Efficient 
Random Acceleration Molecular Dynamics Simulation and Interaction 
Fingerprints Analysis of Ligand Trajectories. 
 
Daria B. Kokha*, Bernd Doser b, Stefan Richtera, Fabian Ormersbacha, Xingyi Cheng a, c, 
Rebecca C. Wadea,d,e* 
 
aMolecular and Cellular Modeling Group, Heidelberg Institute for Theoretical Studies, 
Schloss-Wolfsbrunnenweg 35, 69118 Heidelberg, Germany  
bHeidelberg Institute for Theoretical Studies, Schloss-Wolfsbrunnenweg 35, 69118 
Heidelberg, Germany  
cMolecular Biosciences, Heidelberg University, Im Neuenheimer Feld 282, 69120, Heidelberg, 
Germany 
dCenter for Molecular Biology (ZMBH), DKFZ-ZMBH Alliance, Heidelberg University, Im 
Neuenheimer Feld 282, 69120 Heidelberg, Germany  
eInterdisciplinary Center for Scientific Computing (IWR), Heidelberg University, Im 
Neuenheimer Feld 205, Heidelberg, Germany 
*Daria.Kokh@h-its.org, Rebecca.Wade@h-its.org 
 
ABSTRACT  
The dissociation of ligands from proteins and other biomacromolecules occurs over a wide 
range of timescales. For most pharmaceutically relevant inhibitors, these timescales are far 
beyond those that are accessible by conventional molecular dynamics (MD) simulation. 
Consequently, to explore ligand egress mechanisms and compute dissociation rates, it is 
necessary to enhance the sampling of ligand unbinding.  Random Acceleration MD (RAMD) is 
a simple method to enhance ligand egress from a macromolecular binding site that does not 
require the user to choose a ligand egress reaction coordinate. It thus enables the unbiased 
exploration of ligand egress routes. Furthermore, the RAMD procedure can be used to 
compute the relative residence times of ligands. When combined with a machine-learning 
analysis of protein-ligand interaction fingerprints (IFP), molecular features that affect ligand 
unbinding kinetics can be identified. Here, we describe the implementation of RAMD in 
GROMACS 2020, which provides significantly improved computational performance, with 
scaling to large molecular systems.  For the automated analysis of RAMD results, we 
developed MD-IFP, a set of tools for the generation of IFPs along unbinding trajectories and 
for their use in the exploration of ligand dynamics. We demonstrate that the analysis of ligand 
dissociation trajectories by mapping them onto the IFP space enables the characterization of 
ligand dissociation routes and metastable states. The combined implementation of RAMD and 
MD-IFP provides a computationally efficient and freely available workflow that can be applied 
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to hundreds of compounds in a reasonable computational time and will facilitate the use of 
RAMD in drug design. 
 
I. INTRODUCTION 
Many crystal structures of bound ligand-protein complexes reveal that small molecules are 
often positioned in a cavity that is completely or partially buried in the protein, where no 
clear entrance or exit route can be observed. This suggests that macromolecular 
conformational rearrangements associated with opening and closing of entrance/exit 
channels or tunnels are required for ligand binding and unbinding. While such 
rearrangements are dependent on the mobility of the macromolecule itself, the ligand may 
influence this motion, which results, in particular, in variations in the binding kinetics as well 
as in the binding pocket shape when different ligands bind.  Characterization of the 
dissociation of protein-ligand complexes can give insights into binding and unbinding 
mechanisms and support the design of new therapeutic agents aimed at modulating protein 
function1,2.  Besides, kinetic parameters, such as the unbinding rate, can have a critical 
impact on the in vivo drug efficacy. The physical process of ligand unbinding has proven 
difficult to elucidate as it usually occurs on a timescale that is beyond the simulation times 
feasible in conventional molecular dynamics (MD) simulations. Amongst the different 
strategies for reducing the computational time required to observe ligand unbinding events, 
a number of nonequilibrium MD simulation methods have been found to be computationally 
efficient and to enable the estimation of the kinetics of unbinding processes and the 
elucidation  of the features governing unbinding3–5,6,7,8. 
One approach is to facilitate ligand unbinding from a binding site in a macromolecule by 
applying an additional small, randomly oriented force to the center of mass of the ligand 
during otherwise conventional MD simulations of a solvated protein-ligand complex. This 
method, originally called Random Expulsion Molecular Dynamics9 and later referred to as 
Random Acceleration MD (RAMD) because of its more general scope of application, was 
designed to identify possible ligand egress routes from the bound position. In this approach, 
the magnitude of the additional ligand force or acceleration is kept constant during the 
simulation, while the orientation of the force or acceleration is chosen randomly. The 
displacement of the ligand center of mass relative to the starting position is checked after 
defined time intervals (usually 100 fs) and either a new force direction is chosen randomly if 
the ligand displacement is below a threshold distance, or the force direction is kept for the 
next time interval if the ligand displacement is above the threshold distance. This process is 
repeated until the ligand displacement exceeds a predefined distance from its starting 
position, at which point it is considered to have dissociated from the macromolecule. 
RAMD was first implemented in the ARGOS program9,10,11  and applied to explore the 
dissociation routes of a set of substrates of cytochrome P450 enzymes from their buried 
active sites. 9,12,13,14 The method has since been used in multiple studies, including in its 
implementation in AMBER814 for studying cytochrome P450 enzymes15 and G-protein 
coupled receptors (GPCR) (rhodopsin16, β2-adrenergic receptor17) ,  in GROMACS18 for 
studying ligand dissociation from liver fatty acid binding protein19, and in CHARMM20 for 
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unbinding simulations of retinoic acid from the retinoic acid receptor14. The need to 
implement RAMD in a way that was sustainable in constantly upgraded MD software 
became apparent. This problem was solved by the implementation of RAMD as a tcl script 
wrapping the NAMD21 package in Ref.22,23 The NAMD implementation of RAMD hardly 
needed any additional adaptation even though  the NAMD package was constantly 
developed and updated. However, this implementation has shown limited performance due 
to the intrinsic bottleneck in its parallelization, as after each MD time interval to assess 
ligand motion and decide on changing the force direction, the simulation has to be paused. 
This limiting step hinders the application of the method to larger systems, such as 
membrane proteins or protein complexes, whose simulation speed has particularly 
benefited from recent improvements in the efficiency of MD simulation code parallelization. 
Recently, the NAMD implementation of RAMD was further revised by reverting to using a 
force instead of an acceleration as the input parameter with the aim of estimating relative 
ligand residence times24. Employing a constant force magnitude in simulations for a series of 
different ligands ensures independence of the perturbation effect on the ligand mass. In this 
case, the residence times obtained for different compounds can be compared. For this 
purpose, the time required for the ligand to leave the binding pocket is computed in multiple 
RAMD dissociation trajectories starting from several different snapshots, i.e. coordinates and 
velocities, from MD equilibration runs.  The dissociation times are then used to derive 
relative residence times. This protocol, RAMD, was evaluated on more than 90 inhibitors of 
heat shock protein 90 (HSP90), and showed a good correlation between computed relative 
residence times and experimental data24,25. In Ref. 25,  it was also demonstrated that the 
simulated dissociation trajectory can be further analyzed to decipher the molecular 
determinants that affect ligand residence time by computing and statistically analyzing 
protein-ligand interaction fingerprints, IFP, for the parts of the dissociation trajectories in 
which the ligands are egressing from the binding site. In Ref.25,  OpenEye’s OEChem Toolkit26 
was employed to compute IFPs.    
In the present paper, we first report a new implementation of the RAMD method in the 
GROMACS 2020 MD simulation package27 as a part of the PULL function. This 
implementation enables simulation time to be decreased by up to factor of twnty, 
depending on the system size, compared to the NAMD implementation. We tested the 
performance of the new implementation on two target proteins: the N-terminal domain of 
HSP90, a rather small soluble protein that has been the subject of a number of studies of 
ligand dissociation. 28–31, and the muscarinic receptor M2, a GPCR embedded in a lipid 
bilayer.  
Secondly, we present an open-source software tool set, MD-IFP, for the computation of 
protein-ligand IFPs along simulated MD trajectories. We evaluate the use of MD-IFP on a set 
of over 40 protein-ligand complexes and then demonstrate its application to analysis of 
RAMD simulations of the complexes of HSP90 with three inhibitors that have different 
residence times and distinct binding mechanisms. Although there are several freely available 
software tools for the computation of the three-dimensional structural protein−ligand 
interaction fingerprints from the coordinates of protein-ligand complexes (in PDB format), 
such as  SPLIF32, PLIP33, FLIP34, and LIGPLOT35, none of them is,  to the best of our knowledge, 
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designed to be integrated as a part of automated protocol for MD trajectory analysis. 
Furthermore, we developed an approache to the analysis of the computed IFPs, which 
enable the dissociation routes to be classified and transition states for ligand dissociation to 
be detected. To evaluate the workflow presented in this manuscript, we compared 
simulation results of the new protocol with the previous RAMD implementation, and 
evaluated the accuracy of MD-IFP computations and the ability of the analysis to reveal 
details of dissociation mechanisms. We show that the workflow facilitates effective analysis 
of the main ligand dissociation pathways from the protein binding site and identification of 
the molecular characteristics of semi-stable transition states along these pathways.  
 
THEORY 
A. The RAMD procedure and the choice of MD simulation parameters. 
In the RAMD approach, a small randomly oriented force of the constant magnitude is 
applied to the center of mass, COM, of the ligand during MD simulations. The orientation of 
the force is chosen randomly at the beginning and, after a short simulation interval, its 
orientation is changed randomly if the displacement of the ligand COM is below a specified 
threshold or retained otherwise. Simulation intervals are repeated until the ligand COM 
reaches a pre-defined distance from the starting position, when it is considered to have 
dissociated from its binding partner. There are several parameters that have to be assigned 
in this procedure: (i) the time interval for checking the motion of the ligand COM and 
deciding whether to change the direction of the random force, (ii) the COM displacement 
threshold defining whether the direction of the force should be changed, (iii) the maximum 
displacement of the COM indicating when simulations are stopped, and (iv) the magnitude 
of the force applied. Additionally, the standard MD simulation parameters, such as the type 
of thermostat (and barostat) must be selected. The relaxation time parameter of the 
thermostat can strongly affect the ligand dissociation time, since it influences the dissipation 
of the additional kinetic energy of the ligand due to the external random force.   
The maximum displacement of the ligand COM is defined by the approximate protein extent 
from the center of the binding pocket plus 5-10 Å. A larger distance is better than a smaller 
one since, as soon as the ligand interaction with the protein is lost, its motion is driven by 
the external force and becomes very fast and any reasonable threshold can be reached 
within a few simulation steps. Altering any of the other parameters leads to a change in 
dissociation time, but their effects can compensate each other. For example, a larger force 
magnitude leads to faster dissociation, whereas a longer COM displacement threshold 
makes dissociation slower.   Thus, there is no single choice of suitable MD parameters, but in 
order to be able to evaluate the relative ligand residence times in the RAMD procedure24, 
the parameters must be kept constant in all the simulations of a set of ligands that are to be 
compared. The most obvious criterion for the parameter fitting would be the best 
agreement of the simulation results with experimental residence times for a set of 
compounds. However, given the limited data on experimental residence times, it is generally 
difficult to make an unambiguous choice. Therefore, in the RAMD procedure, the values of 
all parameters except one, the random force magnitude, are fixed for all systems studied.  
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Specifically, for simulations using the NAMD software, the Langevin thermostat and barostat 
are used, both with a relaxation time of 1ps. In the GROMACS implementation, the Nosé–
Hoover thermostat and Parrinello-Rahman barostat are employed (an analysis of the 
GROMACS simulation parameters is given the Section Results A. Benchmark of the 
GROMACS 2020 implementation on three inhibitors of HSP90). The length of the time 
interval for assessing ligand motion and force direction is set to 100 fs and the COM 
displacement threshold is set to 0.025 Å.  While these parameters can be used for all 
protein-ligand systems studied, the magnitude of the random force may need to be adjusted 
according to the properties of the protein-ligand complexes studied. It is recommended to 
use a value of 14 kcal/molÅ for the initial simulations and to adjust this value if too few 
egress events or too fast dissociations are observed. The criteria for the choice of the 
random force magnitude and its adjustment are given in Ref.24 
B. RAMD protocol 
The RAMD  protocol was reported in Refs. 24,25 . Here, we briefly outline the main steps. A 
set of starting snapshots (at least four replicas) is generated using conventional MD 
simulations, ideally from several independent trajectories (started with different coordinates 
and/or velocities). Each starting snapshot is then used to generate a set of 15-30 RAMD 
ligand dissociation trajectories.  The effective residence time for each starting replica is 
defined by the dissociation time, corresponding to 50% of the cumulative distribution 
function (CDF) for the set of RAMD trajectories as illustrated in Fig. 1 A. A bootstrapping 
procedure (5000 rounds with 80% of samples selected randomly) is performed to obtain a 
residence time for each replica, repl, which should converge to a Gaussian-like distribution if 
the sampling is sufficiently large (Fig. 1 B). Otherwise, the number of simulated trajectories 
for this replica should be increased. Additionally, a Kolmogorov-Smirnov (KS) test can be 
done to assess the sampling quality (Fig. 1 C). The final relative residence time, RAMD, is 
defined as the mean of repl over all replicas (Fig. 1 D).  
C. Protein-ligand interaction fingerprints to characterize simulated ligand egress 
trajectories 
We considered the following classes of receptor-ligand interactions to define the IFPs in the 
MD-IFP analysis: hydrophobic (HY), aromatic (AR), hydrogen bond donor (HD) or acceptor 
(HA), salt bridge (IP/IN), halogen bonds (HL), and water bridge (WB). Parameters of IFPs 
computed in each class is summarized in Table 1. The identification of the receptor-ligand IFPs 
is done using:  (i) the RDKit36 software, which identifies the chemical properties of the ligand 
using an input ligand mol2 format file, and (ii) the MDAnalysis37 python library. The latter 
library enables the reading of MD trajectories, independently of their format or the program 
used to generate them, as well as frame-by-frame operations on the trajectories (such as 
computing distances and detecting hydrogen bonds between selected groups of atoms). 
Prerequisites for the IFP calculation are a structure of a protonated protein-ligand complex 
and a ligand structure in mol2 format. For the detection of water bridges, energy minimization 
of the structure of the protein-ligand complex is desirable.   
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Figure 1: Illustration of the use the RAMD method to compute the residence time of an inhibitor of 
HSP90, compound 16, PDB ID: 5J86 (the NAMD implementation was used, the same plots for the 
Gromacs implementation under different thermostat conditions for all ligands are shown in Figs. S1) : 
(A) Cumulative distribution function (CDF) for four sets of 15 RAMD dissociation times, with each 
trajectory in a set starting from the same replica (i.e. the same starting coordinates and velocities); 
the effective residence time obtained from these raw data is indicated by the red solid line at the time 
when the ligand has dissociated in half of the trajectories (1/2 of the maximum value of the CDF, 
which is indicated by the red dashed line); (B) Distribution function of effective residence times 
obtained after bootstrapping of the raw data along with the corresponding Gaussian distribution 
(black line); the mean (log(repl ))  and half-width are indicated by red lines;   (C)  Poisson cumulative 
distribution function (PCDF, black line), 𝑃 = 1 − exp(−𝑡/repl) is compared with the empirical cumulative 
density function (ECDF, blue points) obtained from the dissociation probability distribution; repl is 
indicated by the red line; the results of the Kolmogorov-Smirnov (KS) test are quantified by the 
supremum of the distance D between the Poisson and empirical CDFs (denoted above the plot); (D)  
Bar plot of the relative residence times obtained from each replica. The box extends from the lower to 
upper quartile values of the data, the whiskers show the range of the data, outliers are shown by 
points, the median and mean are shown by orange and dashed red lines, respectively.  The average 
residence time in ns computed from all replicas is shown above the plot.  
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Table 1 Definitions of interactions used to compute IFPs in MD-IFP analysis.  
 
a) Hydrophobic atoms in proteins : all carbon atoms of the protein except those bound with a double bond to oxygen (C=O) 
or nitrogen (C=N) (i.e. backbone C atom, carboxy C in ASP and GLU, amide C in GLN and ASN, guanidino C in ARG), and with 
a single bond to OH or NH3 (as in SER, TYR, LYS and THR side chains) 
b) The cation-pi interaction is orientation-dependent with the strongest interaction when the cation is placed next to an 
aromatic ring; to take into account the case of trimethylamine (ligand), we use a slightly longer distance threshold in the 
case of a ligand cation. 
c) Contact with at least 5 atoms from the list (angle is not considered) 
d) As defined in RDkit; fluorine is also considered as an acceptor. In RDKit, the definitions of the feature types (Donor, 
Acceptor, Aromatic, Halogen, Basic, and Acidic) were adapted from44  
e) Distance between heavy atoms for all interactions except for the H-bond, where the distance between the hydrogen and 
acceptor atoms is considered 
f) as defined in the Charmm force field used in MDAnalysis 
 
Hydrophobic contacts (HY) were defined between the ligand hydrophobic carbon atoms as 
identified by RDKit (carbon atoms adjacent to any O or N are not considered as hydrophobic) 
or the ligand fluorine and the protein carbon (or sulfur) atoms at an inter-heavy atom distance 
of up to 4.0 Å (with an implicit treatment of hydrogen atoms). The definition employed is 
 Type of interaction  Ligand atom 
type or 
atom name 
Protein atoms Criteria: 
maximum 
distance e) (in Å) or 
angle (in degrees) 
HY Hydrophobica) Hydrophobic 
or Fluorine 
S of MET or CYS  
Carbons except for:  CG in ASN ASP; CD in GLU 
GLN ARG; CZ in TYR ARG; CB in SER THR; CE in 
LYS; C in backbone  
4.038 
IP Salt bridges Pos.Ionizable OE* OD* of ASP GLU   
4.539 
IN Salt bridges Neg.Ionizable NH* NZ in ARG LYS    
HD HE in HI2 
AR         - stacking c) 
 
Aromatic   atoms CZ* CD* CE* CG* CH* NE* ND* in PHE 
TRP TYR HIS HI2 HIE HIDc) 
5.5 38 
Cation -  b) PosIonizable  atoms CZ* CD* CE* CG* CH* NE* ND*c) in PHE 
TRP TYR HIS HI2 HIE HID 
5.040,41 
  - Cation b) 
  - Amide  
Aromatic 
 
 
Nitrogens in ARG an LYS; 
backbone nitrogen;  
5.040,41 
5.042  
HL Halogen -  
 
Halogen-carboxyl 
Halogen-S 
Chlorine, 
Bromine, 
Iodine c) 
  
atoms CZ* CD* CE* CG* CH* NE* ND* ins HE TRP 
TYR HIS HIE HID 
O in the backbone or in ASP GLU; 
S in MET and CYS c) 
 3.543  
 
 3.5)43 
3.540  
HD Hydrogen bond Donor  O OC1 OC2 OH2 OW OD1 OD2 SG OE1 OE1 OE2 
ND1 NE2 SD OG OG1  OHf) 
 
3.3, 
100 HA Hydrogen bond Acceptord) N OH2 OW NE NH1 NH2 ND2 SG NE2 ND1 NZ OG 
OG1 NE1 OHf) 
WB Water bridge 
between protein 
and ligand  
Donor/Accept default donor/acceptor as for H-bonds 3.3, 
100 
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consistent with the definition used by the  PLIP33 server, but different from, for example, 
OpenEye’s OEChem Toolkit26, where all carbon atoms are considered to be hydrophobic. 
Hydrogen bonds (HD/HA) were defined by an acceptor-hydrogen distance  3.3 Å38, and a 
donor-hydrogen-acceptor angle  100. A smaller angle is usually chosen to make the 
definition less strict, which is sometimes necessary for the detection of H-bonds in less 
accurate crystal structures or in MD trajectories. 
The aromatic interaction class (AR) includes - interactions (both plane and edge45,38), 
cation -, and amide- interactions. Importantly, all aromatic interactions were defined 
solely on the basis of interatomic distances. The mutual orientation of the interacting 
fragments was taken into account implicitly by setting the minimum number of non-
hydrogen contact atoms to be at least 5 (illustrated in Fig. S2). This definition is, therefore, 
less strict than, for example, in PLIP33 where, for the detection of  -  stacking, the angle 
between the two  rings was defined by a threshold. Nevertheless, with this definition, only 
a few cases were detected where the aromatic rings are slightly tilted relative to the in-plane 
and edge position (see method evaluation below).  
Halogen bonds include interactions between a polarized halogen (not fluorine) atom (Cl, Br, 
I, as a donor), sulfur, and a nucleophile or an aromatic ring (acceptor). The interaction 
distance and orientation of this type of  bond varies across interaction partners with a rather 
wide distribution of the possible values 43. For halogen-aromatic interactions we employed 
an average distance threshold of 3.5 Å without taking into account the mutual orientation of 
the interacting fragments but using a threshold of 5 contact atoms. For halogen-carboxyl 
interactions the C-Hal…O angle should be above 170. We therefore count only halogen-
carboxyl interactions if there are no ligand carbon atoms within the distance of Hal…O plus 1 
Å from the oxygen atom. 
Salt bridges were split into two classes: those with positive (IP) and those with negatively 
(IN) ionizable ligand atoms with a maximum distance from the respective protein heavy 
atoms of 5.0 Å. This assignment was based on a  recent analysis of protein-ligand contacts in 
crystal structures39 (the acceptor-hydrogen distance in salt bridges was found to be within 
2.8-3.3 Å). Note that this distance threshold is smaller than the threshold of 5.5 Å suggested 
in Ref. 46 and employed, for example, in PLIP33. 
Protein-ligand water bridges were identified based on the h-bond detection function of the 
MDAnalysis package (the same H-bond parameters, 3.3Å and 100 were employed).   
Finally, all nonspecific protein-ligand contacts within a threshold of 5Å between heavy atoms 
were stored, along with the number of water molecules in the ligand solvation shell defined 
by a threshold of 3.5 Å between ligand and water heavy atoms. 
D. Trajectory analysis  
IFPs were computed for each of the last 300 snapshots of each RAMD dissociation trajectory 
with the snapshots being saved with a stride of 2 ps. This part of the trajectories comprises a 
short sampling of the bound state and the ligand dissociation phase for the major of 
trajectories (see discussion below).  All structures were superimposed with a single 
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reference structures obtained after initial equilibration of the system. Additionally, to IFPs, 
the number of water molecules in the first water shell around the ligand, the root mean 
squared deviation (RMSD) from the bound position of the ligand, and the ligand centre of 
mass, COM, were computed for each snapshot. 
For each MD snapshot, a binary IFP vector was stored that contains either 0 or 1 for each 
contact showing the presence or absence of a particular interaction. A complete set of IFPs 
for all snapshots, each represented as a binary vector, was combined into a single matrix 
(with frames along the trajectory as rows and IFP vector elements as columns) for the 
further analysis. 
We employed kmeans clustering to identify the states most often visited in the IFP (see 
details of the clustering procedure the Appendix D, Simulation Protocol).  The positions of 
the ligand in all frames that belong to a particular cluster can be projected onto physical 
space by mapping the ligand COMs onto a 3D grid and summing over all snapshots in the 
cluster.  Importantly, the COM distribution in a cluster may not be compact or different 
ligand orientations with close COMs may be assigned to different clusters. The dissociated 
state is defined by the cluster in which no protein-ligand contact is found or in which 
multiple non-specific contacts are present, with the ligand COM spread around the protein. 
In contrast, the clusters describing the bound states of the ligands are usually compact in the 
physical space.  
 
II. RESULTS AND DISCUSSION 
A. Benchmark of the GROMACS 2020 implementation of RAMD  
We benchmarked the GROMACS 2020 implementation of RAMD and its use in the RAMD 
protocol for three inhibitors of HSP90 (compounds 8, 16 and 20 with koff = 0.21 s-1, 1.4 10-2 s-
1 and 1.4 10-4 s-1, respectively,  studied in Ref. 28 ; PDB ID: 5J64, 5K86, and 5LQ9,) selected to 
have distinct binding scaffolds (Fig.2) and large differences in their residence time.  
 
 
Figure 2: Illustration of the binding site of HSP90 with three inhibitors bound (A, B, C - compounds 8, 
16 , and 20 of Ref. 28, PDB ID: 5J64, 5J86, 5LQ9, respectively). These protein-ligand complexes were 
employed for the evaluation of the GROMACS 2020 implementation of RAMD. The ligands are shown 
with cyan carbons and the protein is shown in half-transparent cartoon representation with 
interacting residues in stick representation; water molecules are indicated by red spheres; hydrogen 
bonds are denoted by dashed lines. 
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Figure 3 Relative residence time, RAMD, computed for three inhibitors (compounds 8, 16 and 20) of 
HSP90 and for different simulations conditions plotted against measured residence time. The NAMD 
implementation from Ref.24 and the GROMACS 2020 implementation described here were used. In 
NAMD simulations Langevin thermostat was used, in simulations using the Gromacs  engin– 
Berendsen  and Nosé–Hoover thermostats as well as Langevn dynamics were tested. Additionally, 
Gromacs simulations with thermostat applied to protein+ligand and water+ions sub-systems (2 
groups) and to the whole system (one group) were evaluated.  The simulation of Langevin dynamics 
with GROMACS is about 10-15 % slower than MD using either of the thermostats. 
 
The relative residence times for these compounds obtained from RAMD simulations using 
the NAMD21 software with standard parameters (i.e. Langevin thermostat with a relaxation 
period of 1ps-1) correlate well with the measured values (Fig. 3). For comparison, we 
performed GROMACS simulations using several conditions: Langevin dynamics and no 
thermostat, or Nosé–Hoover or Berendsen thermostat and a Parrinello-Rahman barostat. In 
the latter two cases, the same relaxation time parameter of 1 ps-1 was employed, whereas in 
Langevin dynamics, the relaxation time parameter was doubled to 2 ps-1 as suggested in the 
GROMACS manual. Simulations with GROMACS under Langevin dynamics conditions with a 
relaxation time parameter of 1 ps-1 yielded approximately twice as long residence times for 
all compounds. Since simulation with Langevin dynamics is about 10-15% slower than with a 
Nosé–Hoover thermostat, we used the latter in all subsequent simulations in this study.  We 
also tested using different thermostat groups (either complete system or ions with solvent 
separated from protein and ligand), but did not notice any significant difference.   In 
summary, for RAMD simulations with GROMACS under all tested conditions, the computed 
RAMD is very similar to that obtained with NAMD simulations with only small deviations 
within the computational uncertainty (see Fig. 3 and Fig. S3).  
The performance of the GROMACS RAMD simulations on a GPU node is about 10 times 
better than for the NAMD CPU implementation, giving about 100ns/day for the HSP90 
system (Table 2). This difference is achieved because the limitation of serial RAMD steps is 
overcome and the performance for RAMD is comparable to that for conventional MD in the 
GROMACS GPU implementation. The new implementation also makes the simulation of 
larger systems with RAMD computationally feasible.   For the M2 receptor system, 34 ns/day 
was achieved for both conventional MD and RAMD. 
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Table 2 Performance of conventional MD and the RAMD procedure as implemented in Gromacs and 
in a tcl wrapper for NAMD on a CPU-based architecture. The number of cores given corresponds to 
the best performance (see complete performance plot in Fig. S3). Note that the scaling of NAMD 
workflow is limited by the external tcl script controlling the RAMD simulation procedure. Times are 
given for simulations of two protein-ligand systems: HSP90 and the M2 muscarinic receptor bound to 
compound 20 and iperoxo, respectively. 
System 
Number 
of 
atoms  
Conventional MD RAMD 
NAMD 
(MPI+OMP)a) 
Gromacs  
2020 
(MPI+OMP)a) 
Gromacs 
2020 
single  
GPU b) 
NAMD 
(MPI+OMP) a) 
Gromacs  2020 
(MPI+OMP)a) 
Gromacs 
2020 
single  
GPU b) 
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s/
d
ay
) 
HSP90 27 000 240 110 128 215 138 32 11 128 214 110 
M2 120 000 288 32 128 64 34 96 10 128 66 34 
a)  Intel Xeon E5-2630v3 CPU, 2.40GHz ;  4OMP were used for Gromacs simulations 
b) Intel Xeon Gold 5118 (dual socket), NVIDIA Tesla P40 GPU (Skylake) PCIe 3.0  
 
B. Benchmark of the IFP generation protocol 
We first compared computed protein-ligand IFPs for the three HSP90-ligand complexes with 
those obtained previously28 using the OpenEye OEChem Toolkit26 and those generated by 
the ligand interaction tool of the RCSB PDB41 and PLIP33 (see Table 3). The number of 
hydrophobic contacts, HY, in the present study is generally smaller than in Ref. 28 due to the 
stricter definition of the hydrophobic atoms (i.e. not all carbon atoms are considered as 
hydrophobic).  Apart from HY, there are only a few differences in the IFPs detected by the 
different methods. For example, the definition of aromatic interactions is less strict in the 
present study compared to the OpenEye OEChem Toolkit, whereas it agrees well with the 
ligand interactions identified in the RCSB PDB and PLIP. For h-bond (HD/HA) contacts, 
differences are observed for compounds 8 and 16, where interactions with T184 are missing 
due to the distances being slightly longer than the H-bond detection threshold. The 
computations of water bridges, WB, between the protein and the ligand are found to show 
the most deviations between methods, with several contacts missed by MD-IFP.  
We next benchmarked the IFP detection procedure on 40 complexes from Ref. 34 by 
comparing the MD-IFP results with those of four programs: PLIP33, FLIP34, LPC47, and MOE33 
(the results are summarized in the Supplementary EXCEL Table). Among the 250 PL 
interactions identified by MD-IFP (excluding hydrophobic interactions), 5 were classified as 
false positives (two hydrogen bonds and three aromatic interactions), i.e. they were not 
found by any of the four methods used for the benchmark.  One of the hydrogen bonds is a 
weak hydrogen bond with a fluorine atom considered as an acceptor in PDB ID:3SHY 
(although C-F···H-X is weak, it was shown to be relevant for ligand-protein binding48). 
Remarkably, there are only three false positives amongst the 56 detected aromatic 
interactions, which indicates that using solely the distance criterion for - interactions is 
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sufficient in the majority of cases. Furthermore, the angle-dependent interactions of protein 
residues with halogen atoms are all correctly recognized by MD-IFP.   
Six further interactions (five hydrogen bonds and one salt bridge) were not recognized by 
MD-IFP and classified as false negatives as they were identified by all of the other methods. 
 
 Table 3 Comparison of the IFPs computed for the crystal structures of three HSP90-inhibitor 
complexes  with MD-IFP,  in Ref. 29 using the OpenEye OEChem Toolkit26, from the ligand interaction 
diagram in the RCSB PDB database41, and with PLIP33.  a)  
a) IFPs that are not identified by MD-IFP are shown in bold and those that were not identified by any of the other methods 
used for benchmarking are underscored.   
b)In the RCSB PDB database41, hydrophobic interactions are not included. 
As expected, the major inconsistency between the different methods comes from the WB 
detection. In the present work, 69 WBs were identified. Among them, 23 were not found by 
the benchmark methods (FLIP, PLIP, MOE), which indicates that criteria of WB detections are 
less strict defined as in the present method. However, only four detected WBs were found 
by all the latter methods but were missing in MD-IFP. Inconsistency in the identification of 
water bridges partially arises from differences in the approaches used and in the hydrogen 
bond parameters employed, as well the ambiguity of the assignment of hydrogen 
PDB 
ID 
Ligand MD-IFP Ref. 29 (using 
OEChem) 
Ligand interactions 
in the RCSB PDB 
database41 b) 
PLIP33 
5J64 8 AR: K58  
HD/HA: N51 K58 D93 
GLY97  
WB: L48 S52  
 
HD/HA: D93 G97 T184 
 
 
AR: K58 
HD/HA:  K58 D93 
G97 
WB: L48 S52 T184 
G97 
AR: K58  
HD/HA:  K51 D93 G97 
T184 
WB:  L48 N51 G95 
HY: N51 M98 T184 HY: N51 S52 D54 A55 
I96 GL97 M98 L107 
G108 T109 F138 T184 
V186 
 HY: T184 
5J86 16  AR: K58 F138 W162  
HD/HA: N51 K58 D93 
G97 
WB: L48 S52  
 
HD/HA: N51 D93 G97 
 
AR: N51 K58 W162  
HD/HA:  K58 D93 
G97 T184 
AR: K58 F138 W162  
HD/HA: N51 D93 G97 
T184 
WB: L48 G95 
HY: N51 D54 M98 L10
3 L107 W162 T184 
HY: N51 S52 D54 A55 
D93 I96 G97 M98 L103 
L107 F138 L150 W162   
T184 V186 
 HY: D54 L103 T184 
5LQ9 20 AR: F138 W162 F170  
HD/HA: K58 Y139 184  
S52 D93  
WB: K58 L48 
AR: F138 W162 F170 
HD/HA: D93, Y139 
 
AR: F138, W162 
HD/HA: K58 D93, 
Y139 
WB: L48 S52 D93 
G97 T184 
AR: F138 W162 
HD/HA: K58 D93, 
T184 
WB: S52, K58 
HY: F22 M98 L103 
L107 F138 V150 W162 
F170 
HY: F22 Q23 N51 S52 
D54 A55 A57 K58 D93 
I96 G97 M98 L103 
L107 G108 I110 A111 
F138 Y139 V150 W162 
F170 T184 V186 
 HY: F22 L103 L107 
Y138 V150 Y170 
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orientation (which depends on the procedure used for protonation). Interestingly, almost 
half of the false positives correspond to plausible water bridges between the protein 
backbone and the ligand (some examples are illustrated in Figure S4) 
C. Analysis of ligand dissociation routes  
The workflow developed here includes tools to analyse ligand dissociation routes on the 
basis of clustering in IFP space and a network analysis of the clusters. We show the 
capabilities of these tools by analysing the three inhibitors of HSP90 illustrated in Fig.2. 
These inhibitors differ in size and have quite distinct dissociation pathways:  compounds 8 
and 16 are relatively small and occupy only the ATP binding site, whereas compound 20 has 
a quinoline fragment that occupies the hydrophobic subpocket located under α-helix3 (see 
Fig.2). The dissociation pathways in the IFP space for the three compounds are represented 
as a network between clusters in Fig.4 (from k-means clustering with 8 clusters, see 
Appendix E for details). Nodes denote clusters with their size proportional to the cluster 
population and the color density increases with the average ligand RMSD in the cluster from 
the initial bound position. The clusters are ordered along the x-axis by the average 
displacement of the ligand COM in the cluster from the starting structure. Ligand motion is 
shown as transitions between clusters, which are also used to compute and visualize the net 
flow between nodes (see Fig.4). 
The bound states can be distinguished from intermediate ones by the small value of the 
ligand RMSD relative to the starting ligand position (within 2 Å; bound states are indicated 
by light-orange circles, accordingly). Usually, the RMSD from the starting structure is small 
and there are only slight variations in IFPs for all bound-state clusters. Note, however, that 
we here analyze only the last 300 snapshots and even in the first snapshot analyzed, the 
ligand may have a slightly different position from in the bound state from which RAMD 
simulations were started.  
There is one dissociated state (without, or with no specific, PL contacts) that has a large 
RMSD value (> 10Å) and is colored dark-orange. The rest of the nodes can be considered to 
be metastable transition states along the ligand dissociation pathway. The number of 
transition states naturally depends on the complexity of the egress route. Specifically, for the 
smallest compound, 8, only one intermediate state (cluster 7, Fig. 4A) is identified, which is 
very close to the bound states and differs from them by the loss of the interactions with 
GLY97, MET98, and THR184 (see Fig 4B). This metastable state is shown in Fig. 5A by the 
COM distribution of the cluster members mapped on to a 3D grid. Although less 
pronounced, direct dissociation from the bound state (e. g. cluster 6) is also observed.  All 
dissociation routes lead directly from the ATP binding pocket (Fig. 5B).  
For compound 16, there is also only one intermediate state (cluster 7, Fig.4C, Fig.5C), but it 
is located further from the bound states on the COM scale (about 5 Å).  In the IFP profile, 
only contacts to MET98, LEU107 and PHE138 and a water bridge to ASP93 are preserved, 
while the other interactions are much less pronounced (Fig. 4D).  Unlike compound 8, where 
the hydrogen bond with ASP93, the main anchor point for all compounds bound to the ATP 
binding site of HSP90, is lost only upon complete dissociation (i.e. in the metastable state 8), 
for compound 16 this hydrogen bond is first broken upon transition to the metastable state 
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7, where the compound still retains multiple hydrophobic and hydrogen bonds and gains a 
new water-mediated contact to  ASN51. 
 
Figure 4: Schematic visualization of the RAMD dissociation trajectories (the last 300 frames of each 
trajectory are considered) of 3 inhibitors of HSP90, compounds 8 (A,B), 16 (C,D), and 20 (E,F): (A, C, E) 
Dissociation pathways are shown in a graph representation. Each cluster is shown by a node with the 
size indicating the cluster population. Nodes Ci are positioned on an increasing logarithmic scale of the 
average ligand COM displacement in the cluster from the starting snapshot and the node color denotes 
the averaged ligand RMSD in the cluster from the starting structure. The width of the light-orange 
arrows is proportional to the number of corresponding transitions (Ci  -> Cj ) and (Ci  <- Cj ) between two 
nodes Ci and Cj and the gray arrows indicate the total flow between two nodes (i.e. transitions (Ci  -> Cj 
)-(Ci  <- Cj )). (B, D, F) - IFP composition of each cluster. PL IFPs and nonspecific protein-ligand contacts 
within a distance threshold of 5Å between heavy atoms (in blue and orange pallets, respectively). 
 
The structure of the egress paths becomes more complicated for the bulkier and more 
slowly dissociating compound 20, which passes through multiple intermediate transient 
states during dissociation. In contrast to the smaller compounds, which demonstrate a single 
dissociation route, compound 20 has two possible egress routes (indicated by the red arrows 
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in Fig. 5F).  One route goes directly from the ATP-binding site through the intermediate 
states 6 or 5 (gray and yellow  isosurface in the COM distribution in Fig. 5E).  The other route 
runs through the transient hydrophobic subpocket under α-helix3  (via clusters 5 and 7, (Fig. 
5E).  
 
Figure 5: RAMD dissociation trajectories for 3 inhibitors of HSP90. Compounds 8 (A,B), 16 (C,D), and 
20(E,F) are shown with carbons in cyan and with -helix3 in green.  (A, C, E) – The positions of the main 
metastable states are shown by iso-surfaces of different colors labelled by the corresponding cluster 
number in Fig.4. (B, D, F) – Ligand COM population density from the last 300 frames of each trajectory 
shown by iso-surfaces clipped in the visualization plane. For compound 20, two egress routes are 
indicated by red arrows.  
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The IFP composition of the clusters in Fig. 4E shows that compound 20 loses its hydrogen 
bond to ASP93 in all transition states starting from the cluster 4 and instead forms new 
contacts with -helix3 (such as LEU107, ILE110, ALA111). These contacts are all rather 
nonspecific (e.g. hydrophobic), which indicates that the long dissociation times for the 
pathway under -helix3 are mainly due to limited space in the dissociation tunnel rather 
than the formation of specific interactions.   
 
III. CONCLUSIONS 
In this paper, we present an efficient implementation of the RAMD method along with 
analysis tools for the exploration of ligand egress routes and for the prediction of relative 
protein-ligand residence times using the RAMD approach28,29. Despite the promising 
efficiency and accuracy of the method, the preceding implementation suffered from two 
important limitations: (i) the parallel scaling performance of MD simulations was diminished 
as the random force adjustment steps were serially wrapped around the MD engine, and (ii) 
difficulties in the quantitative analysis of large numbers of ligand dissociation trajectories, 
which hindered the detection of possible egress routes and mechanisms, and their statistical 
analysis. To overcome these two bottlenecks, we developed a new open-source workflow 
that includes: (i) a new implementation of the RAMD method in the GROMACS MD 
simulation package that significantly improves simulation performance relative to the 
previous implementation in NAMD, and (ii) a Python-based workflow for automated analysis 
of ligand egress trajectories, which includes computation of residence times for series of 
compounds, and the MD-IFP tool set  for generation of protein-ligand interaction 
fingerprints along ligand dissociation trajectories, and analysis of ligand dissociation 
pathways in the IFP space. 
The new implementation of the RAMD protocol in the GROMACS PULL function speeds up 
simulations of ligand dissociation by up to a factor of twenty for a systems 27 103 atoms and 
a factor of 6 for of 120 103 atoms relative to the previous implementation in a tcl script with 
the NAMD engine. We evaluated the new implementation for complexes of three inhibitors 
with HSP90, a system previously studied in detail28, using different parameters for the 
underlying MD protocol. We found that the results of the RAMD procedure obtained using 
the two MD simulation programs are the same within the uncertainty of simulations. Then 
we compared the performance of the two implementations on systems of different sizes. 
These simulations showed that the sampling of ligand egress for computing a  relative 
residence time (usually about 60 ligand dissociation trajectories of several nanoseconds 
duration were required) could be performed within about half a day on one GPU node  for a 
relatively small system (the solvated globular HSP90 domain with 27 500 atoms) and within 
two days for a larger system (a GPCR protein embedded in a lipid bilayer having about 120 
000 atoms). Taking into account that the individual RAMD simulations can be performed 
independently and, thus effectively parallelized, the method provides the possibility to 
compute relative residence times for multiple drug candidates within a few days on a GPU 
cluster. Furthermore, we report a protocol for processing the output RAMD trajectories that 
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enables the automated computation of relative residence times, their statistical assessment, 
and the comparison of computed with experimental data, if available.   
Analysis of the dissociation trajectories is another important aspect of the new workflow. 
The RAMD method is aimed at the quick estimation of the dissociation rates and requires 
tens of trajectories to be generated per ligand to ensure reasonably small uncertainty in the 
computed values. Nonetheless, even hundreds of generated trajectories cannot completely 
cover the full configuration space of the multidimensional ligand-protein dissociation 
landscape. For this reason, reconstruction of the protein-ligand dissociation free energy 
landscape or even the free energy profile of a single dissociation pathway, is not feasible. 
One should, however, expect that the generated trajectories bear important information 
about protein-ligand interactions that affect residence time if the derived residence times 
provide the correct trends for a set of ligands. Therefore, we developed MD-IFP to generate 
protein-ligand IFPs for MD trajectories. We benchmarked MD-IFP on 40 protein-ligand 
complexes and found that it identified similar IFPs to several available methods. Then we 
applied the procedure to trajectories of three complexes of HSP90 with inhibitors that have 
very different residence times, sizes, and binding poses and, thus, IFP profiles. We showed 
how the workflow could be used to explore the increasing complexity of the dissociation 
pathway in the IFP space on increasing ligand size, which, in this case, is correlated with 
increasing residence time. 
In summary, the workflow reported provides an efficient computational engine for the 
estimation of the relative residence times of compounds against a macromolecular target 
and tools for obtaining insights into the underlying mechanisms determining ligand 
unbinding kinetics. It may thus facilitate the assessment and selection of drug candidates in 
the early stages of a drug development pipeline.   
 
SUPPLEMENTARY MATERIAL 
Figures S1-S5 provide additional results:  
Figures S1: RAMD simulations using the GROMACS implementation for three HSP90 
compounds showing a comparison of using the Langevin dynamics, Berendsen, and Nose-
Hoover thermostats; Figure S2: Illustration of the procedure for detection - interactions 
with MD-IFP; Figure S3: Plot showing performance of different implementations for two test 
examples:  HSP90 and Muscarinic receptor M2; Figure S4: Illustration of water bridges 
identified by MD-IFP; Figure S5: Illustration of the effect of cluster number on the structure 
of the simulated dissociation pathways; Figure S6: Illustration of dissociation networks 
generated for the systems shown in Figure S5 using clustering based on the IFP only 
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Tutorials for the RAMD protocol implemented with NAMD and GROMACS, as well as the IFP 
analysis of ligand dissociation trajectories, are available on KBbox:  https://kbbox.h-
its.org/toolbox/ 
Python scripts of the IFP generation and analysis are available at: https://github.com/HITS-
MCM/MD-IFP 
The data that supports the findings of this study are available within the article and on 
reasonable request to the authors. 
Excel table containing results of the benchmark of the MD-IFP protocol for 40 protein-ligand 
complexes is available upon requires. 
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APPENDICES 
METHODOLOGY/IMPLEMENTATION/TECHNICAL DETAILS 
A. tcl implementation of RAMD in NAMD  
In the NAMD-based protocol for RAMD simulations, a tcl script 9,12 wrapped around the MD 
is employed. The script computes the ligand displacement after each short (50 timesteps) 
MD interval and recomputes the force if necessary.  It sends a kill signal to stop the 
trajectory when the ligand displacement from its initial position reaches the predefined 
dissociation threshold distance. In the recent version the procedure of selection force 
orientation was improved to ensures uniform distribution of the vector direction was 
(version 5.05 https://www.h-its.org/downloads/ramd/ ) 
B. Implementation of RAMD in GROMACS 
The RAMD implementation is based on the ‘pull’ code in GROMACS. The key feature of the 
pull code is that forces are applied between the centers of mass of pairs of atom groups. 
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Core functionalities like the usage of MPI and/or GPU are already included and the 
performance has been optimized. In order to keep the interface as user-friendly as possible, 
only RAMD settings have to be provided. All pull code-related settings are handled 
automatically by the RAMD implementation during the GROMACS preprocessing step. 
A function for changing the pull direction during the simulation is not available in the pull 
code. Therefore, the random force direction is decomposed into three orthogonal unit 
vectors (1,0,0), (0,1,0) and (0,0,1) and only the projected force values have to be adjusted. 
For testing that the force directions were distributed in a spherically uniform fashion, a 
sphere was divided into 32 longitudinal bins and a large number (1 billion) of force directions 
was generated randomly. The procedure was repeated in each direction in space to ensure a 
uniform spherical distribution. By counting the number of force vectors assigned to the bins, 
we could ensure that the force generator indeed covers the whole sphere uniformly. 
C. Validation of MD-IFP on a set of crystal structures of protein-ligand complexes 
For the validation, we chose the same set of structures of protein-ligand complexes that was 
used to validate FLIP33. It consists of 50 RCSB PDB entries and their corresponding ligand and 
chain identifiers. Hydrogens were added using Chimera45 1.14, using the “unspecified” 
protonation state with the consideration of hydrogen bonds. A protein chain, a ligand and 
water molecules were extracted using the pdb-file processing tools in the Biopython (version 
1.76) package49. For structures containing multiple conformations, conformation A was 
extracted and all other conformations were discarded. The ligand was saved in mol2 format. 
For structures containing azole, amidine and urea groups, Chimera failed to produce correct 
mol2 files and therefore, these files were manually corrected. If there was no apparent 
reason for the mol2 file not working, we created the mol2 file using MOE50. 
Altogether 10 structures were removed from the original dataset because we were either 
unable to generate usable mol2 files or the structures were unsuitable for our processing 
pipeline (e.g. having two ligands covalently bound together), or other methods using for 
benchmark were unable to generate results. Thus, our final benchmark set consisted of 40 
structures. 
The IFPs generated by MD-IFP were compared to the results from FLIP33, PLIP32 ,  LPC46, and 
MOE50. We considered the interactions detected by MD-IFP as False Positives (FP) if they 
could not be detected by any of these four methods and as False Negatives (FN) if all four 
methods detected them but they were not found by MD-IFP. Since water bridges and 
halogen bonds could not be detected using LPC, we classified them as FN if FLIP, PLIP, and 
MOE detected the interaction.  
Hydrophobic interactions were not considered, since their definition is not as clear cut as for 
the other interactions and one would naturally expect a lot of variation between methods 
for them. Except for MOE, none of the benchmark methods differentiate between donated 
and accepted hydrogen bonds, both indicated by the abbreviation HB for hydrogen bond in 
the “missing interaction” column. Since we consider fluorine to make hydrophobic 
interactions, halogen bonds with fluorine were excluded from the analysis. Interactions with 
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metal ions and cofactors were excluded, since the ability to detect them has not yet been 
implemented in MD-IFP.  
D. Details of MD simulations 
System setup and force field parameters 
The structures of the HSP 90-inhibitor complexes were prepared from the crystal structures 
with PDB ID: 5J64, 5J86, 5LQ9 for compounds 8, 16, and 20, respectively, as described in 
Ref.28.  The structure of the M2 muscarinic GPCR with the orthosteric ligand, iperoxo, bound 
was prepared from the structure with PDB ID 4MQT with the allosteric compound 
LY2119620 removed. The CharmmGUI51 web server was used to embed the GPCR in a pure 
1-palmitoyl-2-oleoylphosphatidylcholine (POPC) bilayer and perform protein protonation, 
generation of topology files and coordinates for AMBER simulations. Systems were solvated 
with TIP3P52 water molecules with a margin of at least 10 Å from the protein and Na+ and Cl- 
ions were added to ensure system neutrality at an ion concentration of 150mM. Iperoxo was 
modelled in its protonated state (charge +1e). For all systems, the Amber ff1453 and GAFF54 
force fields for protein/lipid and ligands, respectively, were employed. RESP partial atomic 
charges for ligands were computed using GAMESS55 calculations of the electron density 
population at the HF/6-31G*(1D) level and Amber tools.   
Simulation protocol 
In all cases, the system was first energy minimized and equilibrated using the Amber18 
software56.  For HSP90, a step-wise minimization, heating and equilibration  was done as 
described elsewhere28. The system with the membrane protein was first minimized 
(restraints on all heavy atoms except water and ions of 1000, 500, 100, 50, 10, 1, 0.5, 0.1, 
0.05, 0.01 kcal mol-1 Å-2 for 1000 steps of conjugate gradient and then 10000 steps without 
restraints), then heated in 200 ps steps  with restraints of 100 kcal mol-1 Å-2  on all heavy 
atoms except water and ions up to 100 K (NVT- Langevin  tau = 1 ps-1)  and then in an NPT 
ensemble (7 ns) up to 310K with decreasing restraints of 50, 30, 5 kcal mol-1 Å-2  and finally 
without restrains. Then we followed the protocol for the setup of simulations of membrane-
containing systems on GPUs (https://ambermd.org/tutorials/advanced/tutorial16/) that 
consists of 10 consecutive simulations of 5ns duration (which is required because the GPU 
code does not recalculate the non-bonded list cells during a simulation).  Finally, we ran a 
further simulation of 300 ns under NPT (Langevin thermostat with a Berendsen barostat) 
conditions to ensure equilibration of the whole system. For all simulations, a cutoff of 10 Å 
for nonbonded Coulombic and Lennard-Jones interactions and periodic boundary conditions 
with a Particle Mesh Ewald treatment of long-range Coulombic interactions were used. A 2 fs 
time step was employed with bonds to hydrogen atoms constrained using the SHAKE 
algorithm57. 
The equilibrated systems were then used in the NAMD and GROMACS tauRAMD protocols. 
The protocol employed for RAMD simulations using the NAMD21 software was reported 
elsewhere24 and can be found online at (kbbox.h-its.org).   
To perform simulations in GROMACS58, the final output coordinate and topology files were 
transferred from Amber to GROMACS using ParmEd. Then we first performed short NVT 
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simulations (Berendsen thermostat, 30 ns) and then generated four trajectories under NPT 
conditions (Nosé–Hoover thermostat and Parrinello-Rahman barostat, 30ns). Each trajectory 
was started with velocities generated from the Maxwell distribution to ensure trajectory 
diversity. 
RAMD simulations were performed with GROMACS at NPT conditions (Nosé–Hoover 
thermostat and Parrinello-Rahman barostat) except for the cases where different 
thermostats were evaluated. Displacement of the ligand COM was checked every 100 fs and 
then the random force orientation was either retained (if the ligand COM had moved by at 
least 0.025 Å) or changed randomly otherwise. Simulations were stopped when the ligand 
COM had moved further than 30 Å from its original position in HSP90and further than 50 Å 
in the M2 receptor. Coordinates were saved at 1 ps intervals. 
E. Analysis Protocols 
Preprocessing 
IFPs were generated for the 300 last frames of each trajectory (superimposed with the last 
snapshot of the equilibration trajectory employed as a reference), thus discarding the 
majority of the frames where the ligand retains a bound state position. The IFPs for all 
frames, together with nonspecific contacts within a threshold distance of 5 Å, were collected 
in one binary matrix for each compound filled with 0/1 values for each particular contact (i.e. 
residue and type of interaction) and frame. Additionally, RMSD of the ligand and protein 
relative to reference as well as the ligand COM coordinates and the number of water 
molecules in the ligand solvation shell were stored. 
Clustering 
We employed k-means clustering as  implemented in the scikit-learn package59 to detect the 
most visited regions in the IFP space.  The clustering was done on the set of IFP vectors and 
unspecific contacts. 
The selection of the number of clusters to be generated is the main bottleneck in the k-
means approach. In the present case, we chose the number of clusters from a trade-off 
between the difficulty in analyzing multiple clusters and the blurring of the protein-ligand 
contact specificity in the case of a small number of clusters.  Specifically, we selected the 
minimal number of clusters, 8, when transient states in dissociation trajectories were clearly 
recognized for all three compounds (see visualization of dissociation trajectories with 
smaller and larger numbers of clusters in Fig. S5.). Note, that the larger number of clusters 
does not change the general pattern of dissociation behavior for any of the three ligands.   
Using just IFP for clustering, instead of a combination of IFP and nonspecific protein-ligand 
contacts, does not change this pattern either, although the minimum number of clusters 
required to reveal a transition state increases from 8 to 10 (Fig.S6) 
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Figure S1 RAMD simulations using the GROMACS implementation for three HSP90 compounds 
showing a comparison of using the Langevin dynamics (tau = 2 ps), Berendsen and Nose-Hoover 
thermostats (tau = 1 ps): (A) Compound 8:  , the computed residence time averaged over 4 replicas is 
0.25±0.09 ns, 0.42±0.28 ns, and 0.25±0.09 ns respectively. For comparison, in NAMD simulations 
Langevin thermostat with tau = 1 ps), the computed residence time is 0.22±0.06 ns (not shown in the 
plot); (B) Compound 16:  averaged residence time is 1.15±0.27 ns, 1.3±0.42 ns, and 1.3±0.42 ns, 
respectively; in NAMD simulations the residence time is 1.4±0.29 ns (see Fig. 1 of the main text); (C) 
Compound 20:  averaged residence time is 5.5±1.17 ns, 3,73±0.86 ns, and 5.02±1.22ns, respectively; in 
NAMD simulations the residence time is 4.36±1.8 ns (not shown in the plot). 
29 
 
 
Figure S2 Illustration of detected - interactions with MD-IFP for two crystal structures with PDB 
identifiers (A, B) slightly tilted in-plane (PDB ID 1BMA) and (C,D) edge-to-plane (PDB ID 1L2S) 
interactions. (A,B) In the in-plane interaction, both aromatic rings (the ligand benzene fragment and 
F223) have more than 5 atoms in the interaction list of atoms within 5.5Å. (C,D) In the edge interaction, 
the ligand fragment has contacts with 5 (C) or 3 (D) aromatic atoms of TYR150.  Both cases were 
recognized as - interactions by MD-IFP and by the ligand interaction tool in the RCSB PDB and by 
LPC, but not by FLIP or PLIP. 
 
 
Figure S3 Plot showing performance of two different implementations of the RAMD protocol – in 
NAMD and Gromacs software for two test examples:  HSP90 (27 000 atoms) and Muscarinic receptor 
M2 (120 000 atoms), see more details in Table 2 of the main text 
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Figure S4 Illustration of water bridges identified by MD-IFP, but not found by any of the benchmark methods 
and therefore categorized as false positive in the benchmark of MD-IFP. Identified H-bonds are marked by dashed 
lines. 
 
 
Figure S5. Illustration of the effect of cluster number on the structure of the simulated dissociation 
pathways. IFP and nonspecific protein-ligand contacts were used for clustering. Plots are shown for 
specification of 4, 6 and 10 clusters in the k-means clustering of the RAMD trajectories for the egress 
of compounds 8, 16 and 20 from HSP90.  
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 Figure S6. Illustration of dissociation networks generated for the systems shown in Figure S5 using 
clustering based on the IFP only. 
 
 
